Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial (Q34471264)

2 August 2017

Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial (English)

1 reference

2 August 2017

0 references

0 references

tuberculosis in India

1 reference

1 reference

10

Marek Smieja

1 reference

2 August 2017

Peter Daley

1

1 reference

2 August 2017

Vijayakumar Jagannathan

2

1 reference

2 August 2017

K R John

3

1 reference

2 August 2017

Joy Sarojini

4

1 reference

2 August 2017

Asha Latha

5

1 reference

2 August 2017

Reinhold Vieth

6

1 reference

2 August 2017

Shirly Suzana

7

1 reference

2 August 2017

Lakshmanan Jeyaseelan

8

1 reference

2 August 2017

Devasahayam J Christopher

9

1 reference

2 August 2017

Dilip Mathai

11

1 reference

2 August 2017

8 April 2015

1 reference

Lancet Infectious Diseases

2 August 2017

1 reference

2 August 2017

15

1 reference

2 August 2017

528-534

1 reference

2 August 2017

5

1 reference

Cod-liver Oil in Phthisis

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Vitamin D, cognition, and dementia: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

The influence of vitamin D intake on serum calcium in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pu

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

A single dose of vitamin D enhances immunity to mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Estimates of optimal vitamin D status

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

Tuberculosis therapy: past, present and future.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970053-8

7 January 2021

10.1016/S1473-3099(15)70053-8

Identifiers

DOI

1 reference

2 August 2017

1 reference